Structures by: Cheon S.
Total: 7
C22H34Cu2I2N2S2
C22H34Cu2I2N2S2
CrystEngComm (2013) 15, 3 451
a=14.7762(3)Å b=12.6035(2)Å c=14.8514(3)Å
α=90.00° β=93.0440(10)° γ=90.00°
C33H51Cu7I7N3S3,C4H10O
C33H51Cu7I7N3S3,C4H10O
CrystEngComm (2013) 15, 3 451
a=13.7721(6)Å b=14.5307(7)Å c=16.5618(8)Å
α=104.3740(10)° β=110.6920(10)° γ=103.5030(10)°
C127H153F12N10O29Ru4S4
C127H153F12N10O29Ru4S4
Dalton transactions (Cambridge, England : 2003) (2014) 43, 16 6032-6040
a=32.701(7)Å b=18.016(4)Å c=23.371(5)Å
α=90.00° β=114.20(3)° γ=90.00°
Dimethyl (<i>E</i>)-1-methyl-2-(methylcarbamoyl)ethenyl phosphate
C7H14NO5P
Acta Crystallographica Section E (2011) 67, 3 o584
a=10.0498(2)Å b=11.3501(2)Å c=10.4587(2)Å
α=90.00° β=115.3770(10)° γ=90.00°
<i>O,O</i>-Dimethyl <i>S</i>-phthalimidomethyl phosphorodithioate
C11H12NO4PS2
Acta Crystallographica Section E (2010) 66, 8 o2137
a=8.3428(18)Å b=8.6014(19)Å c=10.218(2)Å
α=85.253(10)° β=81.478(10)° γ=83.961(9)°
2-(1,3-benzothiazol-2-yloxy)-<i>N</i>-methyl-<i>N</i>-phenylacetamide
C16H14N2O2S
Acta Crystallographica Section E (2010) 66, 12 o3153
a=11.2708(6)Å b=15.7112(9)Å c=19.9579(8)Å
α=90.00° β=122.997(2)° γ=90.00°
1-[2-(2,4-dichlorophenyl)-2-(prop-2-enyloxy)ethyl]-1<i>H</i>-imidazole
C14H14Cl2N2O
Acta Crystallographica Section E (2011) 67, 6 o1459
a=7.9374(6)Å b=13.4144(12)Å c=13.4790(10)Å
α=90.00° β=103.386(5)° γ=90.00°